Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Fulgent Genetics, Inc. | Director | Common Stock | 2K | $53.4K | $26.69 | May 18, 2022 | Direct |
LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Director | Options to Purchase Common Stock | 5.79K | Sep 30, 2024 | Direct | ||
LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Director | Warrants to Purchase Common Stock | 5.26K | Sep 30, 2024 | By Sino-American Cancer FDD | ||
LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Director | Options to Purchase Common Stock | 4.53K | Jun 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Sep 30, 2024 | 1 | $0 | 4 | Oct 29, 2024 | Director |
LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Jun 30, 2024 | 2 | $0 | 4 | Jul 2, 2024 | Director |
LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Jun 30, 2023 | 1 | $0 | 4 | Jul 7, 2023 | Director |
LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Jun 30, 2022 | 1 | $0 | 4 | Aug 3, 2022 | Director |
FLGT | Fulgent Genetics, Inc. | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Jun 30, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
FLGT | Fulgent Genetics, Inc. | May 20, 2021 | 1 | $0 | 4 | May 24, 2021 | Director |